TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets

Intangible Assets

6 Months Ended

Jun. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Note 8 - Intangible Assets

Intangible assets as of June 30, 2015 and December 31, 2014 and the movements for the three months then ended are as follows:

			Distributor &
	Patents &		Customer
	Trademarks		Relationships		Totals
*Cost or Deemed Cost*
At December 31, 2014	$	3,851,495	$	1,270,639	$	5,122,134
Additions		-		-		-
Disposals		-		-		-
At June 30, 2015	$	3,851,495	$	1,270,639	$	5,122,134

*Accumulated Amortization*
At December 31, 2014	$	1,675,430	$	1,270,639	$	2,946,069
Amortization Charge		129,286		-		129,286
Disposals		-		-		-
At June 30, 2015	$	1,804,716	$	1,270,639	$	3,075,355

*Net Book Value*
At December 31, 2014	$	2,176,065	$	-	$	2,176,065
At June 30, 2015	$	2,046,779	$	-	$	2,046,779

Amortization expense was $64,643 and $129,286 for the three and six months ended June 30, 2015 and $64,643 and $129,286 for the three and six months ended June 30, 2014.